Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2008 1
2011 2
2012 1
2013 2
2014 3
2015 1
2016 6
2017 6
2018 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion.
Watermann C, Pasternack H, Idel C, Ribbat-Idel J, Brägelmann J, Kuppler P, Offermann A, Jonigk D, Kühnel MP, Schröck A, Dreyer E, Rosero C, Nathansen J, Dubrovska A, Tharun L, Kirfel J, Wollenberg B, Perner S, Krupar R. Watermann C, et al. Among authors: schrock a. Clin Cancer Res. 2021 Jan 15;27(2):632-644. doi: 10.1158/1078-0432.CCR-20-0197. Epub 2020 Oct 27. Clin Cancer Res. 2021. PMID: 33109740
MERTK as a novel therapeutic target in head and neck cancer.
von Mässenhausen A, Sanders C, Thewes B, Deng M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Heasley L, Brägelmann J, Perner S. von Mässenhausen A, et al. Among authors: schrock a. Oncotarget. 2016 May 31;7(22):32678-94. doi: 10.18632/oncotarget.8724. Oncotarget. 2016. PMID: 27081701 Free PMC article.
Endovascular treatment of epistaxis: indications, management, and outcome.
Strach K, Schröck A, Wilhelm K, Greschus S, Tschampa H, Möhlenbruch M, Naehle CP, Jakob M, Gerstner AO, Bootz F, Schild HH, Urbach H. Strach K, et al. Among authors: schrock a. Cardiovasc Intervent Radiol. 2011 Dec;34(6):1190-8. doi: 10.1007/s00270-011-0155-5. Epub 2011 Apr 7. Cardiovasc Intervent Radiol. 2011. PMID: 21472510
PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma.
Müller T, Braun M, Dietrich D, Aktekin S, Höft S, Kristiansen G, Göke F, Schröck A, Brägelmann J, Held SAE, Bootz F, Brossart P. Müller T, et al. Among authors: schrock a. Oncotarget. 2017 May 2;8(32):52889-52900. doi: 10.18632/oncotarget.17547. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881780 Free PMC article.
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.
von Mässenhausen A, Sanders C, Brägelmann J, Konantz M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Lengerke C, Perner S. von Mässenhausen A, et al. Among authors: schrock a. Int J Cancer. 2016 Nov 15;139(10):2359-69. doi: 10.1002/ijc.30279. Epub 2016 Jul 30. Int J Cancer. 2016. PMID: 27434411 Free article.
Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma.
Adler D, Offermann A, Halbach R, Vogel W, Braun M, Kristiansen G, Bootz F, Wenzel J, Mikut R, Lengerke C, Reischl M, Schröck A, Perner S. Adler D, et al. Among authors: schrock a. Am J Pathol. 2015 Apr;185(4):1114-22. doi: 10.1016/j.ajpath.2014.12.010. Epub 2015 Mar 16. Am J Pathol. 2015. PMID: 25791637 Free article.
Sudden sensorineural hearing loss after heroin injection.
Schrock A, Jakob M, Wirz S, Bootz F. Schrock A, et al. Eur Arch Otorhinolaryngol. 2008 May;265(5):603-6. doi: 10.1007/s00405-007-0495-6. Epub 2007 Oct 30. Eur Arch Otorhinolaryngol. 2008. PMID: 17968577
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression.
von Mässenhausen A, Brägelmann J, Billig H, Thewes B, Queisser A, Vogel W, Kristiansen G, Schröck A, Bootz F, Brossart P, Kirfel J, Perner S. von Mässenhausen A, et al. Among authors: schrock a. Int J Mol Sci. 2016 Dec 22;18(1):7. doi: 10.3390/ijms18010007. Int J Mol Sci. 2016. PMID: 28025482 Free PMC article.
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
von Mässenhausen A, Deng M, Billig H, Queisser A, Vogel W, Kristiansen G, Schröck A, Bootz F, Göke F, Franzen A, Heasley L, Kirfel J, Brägelmann J, Perner S. von Mässenhausen A, et al. Among authors: schrock a. Target Oncol. 2016 Oct;11(5):631-642. doi: 10.1007/s11523-016-0431-z. Target Oncol. 2016. PMID: 27053219
24 results